Both in Pharmaceuticals
Kailera Therapeutics vs Supernus Pharmaceuticals
Over the past year KLRA returned −9.8% and SUPN returned −32.4%; their daily moves had a correlation of 0.16.
KLRA −9.8% SUPN −32.4%Growth of $1, one year, split-adjusted
| Metric | KLRA | SUPN |
|---|---|---|
| Price | $12.58 | $28.15 |
| Market cap | $1.63B | $1.64B |
| Today | +3.54% | −32.85% |
| 1 month | +16.1% | −34.2% |
| 6 months | — | −42.8% |
| Year to date | — | −43.4% |
| 1 year | — | — |
| Revenue growth (YoY) | — | +18.0% |
| Gross margin | — | 88.1% |
| Net margin | — | 9.2% |
| P/E (TTM) | — | — |
| Price / sales | — | 1.9× |
| Net cash | $916.7M | $359.5M |
| Dividend yield | — | 28.88% |
| Volatility (60d) | — | 86.0% |
| Short % of float | 9.1% | 7.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).